Comprehensive Evaluation of the Specificity of Rapamycin as an mTOR Inhibitor
F. Artoni, N. Grutzmacher, C. Demetriades
This study evaluates rapamycin's specificity as an mTOR inhibitor using gene-edited cells, showing minimal off-target effects on transcriptome and proteome.
bioRxiv · Dec 10, 2022 · PreprintCell Biology